TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/19/25 16:10 | 5/14/25 | TARA | Protara Therapeutics, Inc. | Health | BioPrd | Biological Products, (No Diag | Levy Richard S | NY | D | P.a | 64 | 3.19 | 0 | 20 | 65 | 51 | D | ||||||||||||||||
5/16/25 16:05 | 5/14/25 | TARA | Protara Therapeutics, Inc. | Health | BioPrd | Biological Products, (No Diag | Levy Richard S | NY | D | P | 64 | 3.19 | 0 | 20 | 65 | 51 | D | ||||||||||||||||
3/24/20 16:50 | 3/20/20 | KOD | Kodiak Sciences Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Levy Richard S | CA | D | P | 44 | 44.33 | 0 | 1 | New | 1 | D | |||||||||||||||
8/24/17 16:04 | 8/23/17 | MDGL | Madrigal Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Levy Richard S | PA | D | P | 32 | 16.12 | 0 | 2 | 28 | 9 | D | |||||||||||||||
8/23/17 16:03 | 8/22/17 | MDGL | Madrigal Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Levy Richard S | PA | D | P | 57 | 16.12 | 0 | 4 | 100 | 7 | D | |||||||||||||||
8/22/17 16:05 | 8/21/17 | MDGL | Madrigal Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Levy Richard S | PA | D | P | 56 | 15.88 | 0 | 4 | New | 4 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |